In accordance with this observation, Boelte et al. (2011) [47] reported that genetic deletion or inactivation of RGS2 results in a significant reduction of tumor growth and of MCP-1 in a Rgs2−/− tumor myeloid derived suppressor cells (MDSCs) mouse model. The gene discussed is CCL2; the disease is neoplasm.